IMNN
Income statement / Annual
Last year (2024), Imunon, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Imunon, Inc.'s net income was -$18.62 B.
See Imunon, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
$500,000.00 |
| Cost of Revenue |
$0.00
|
$720,005.00
|
$731,629.00
|
$702,918.00
|
$11.34 M
|
$13.07 M
|
$11.07 M
|
$13.08 M
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$720,005.00
|
-$231,629.00
|
-$202,918.00
|
-$10.84 M
|
-$12.57 M
|
-$10.57 M
|
-$12.58 M
|
$500,000.00
|
$500,000.00
|
| Gross Profit Ratio |
0
|
0
|
-0.46
|
-0.41
|
-21.69
|
-25.13
|
-21.13
|
-25.16
|
1
|
1
|
| Research and Development Expenses |
$11.64 B
|
$11.29 M
|
$11.73 M
|
$10.62 M
|
$11.34 M
|
$13.07 M
|
$11.87 M
|
$13.08 M
|
$14.62 M
|
$14.66 M
|
| General & Administrative Expenses |
$7.49 B
|
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.49 B
|
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
| Other Expenses |
$0.00
|
$0.00
|
$5.40 M
|
$1.62 M
|
-$1.30 M
|
$3.19 M
|
$3.63 M
|
$651,971.00
|
$733,000.00
|
-$259,451.00
|
| Operating Expenses |
$19.13 B
|
$21.03 M
|
$25.42 M
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
| Cost And Expenses |
$0.00
|
$21.03 M
|
$25.42 M
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
| Interest Income |
$0.00
|
$960,545.00
|
$502,578.00
|
$18,145.00
|
$66,553.00
|
$442,987.00
|
$331,780.00
|
$26,041.00
|
$31,262.00
|
$186,322.00
|
| Interest Expense |
$0.00
|
$0.00
|
$4.57 M
|
$557,000.00
|
$1.29 M
|
$1.39 M
|
$712,025.00
|
$91,756.00
|
$693,000.00
|
$1.36 M
|
| Depreciation & Amortization |
$0.00
|
$720,005.00
|
$731,629.00
|
$702,918.00
|
$741,524.00
|
$721,665.00
|
$356,859.00
|
$553,010.00
|
$1.03 M
|
$424,966.00
|
| EBITDA |
-$19.13 B |
-$19.88 M |
-$31.71 M |
-$20.88 M |
-$21.30 M |
-$16.55 M |
-$21.23 M |
-$19.76 M |
-$20.30 M |
-$20.67 M |
| EBITDA Ratio |
0
|
0
|
-39.05
|
-38.77
|
-37.96
|
-32.42
|
-33.49
|
-34.47
|
-39.83
|
-40.99
|
| Operating Income Ratio |
0
|
0
|
-49.84
|
-42.01
|
-36.97
|
-41.13
|
-42.13
|
-36.94
|
-41.3
|
-41.69
|
| Total Other Income/Expenses Net |
$512.20 M
|
$235,068.00
|
-$12.54 M
|
-$1.15 M
|
-$4.84 M
|
$1.90 M
|
-$1.24 M
|
-$1.93 M
|
-$1.40 M
|
-$1.61 M
|
| Income Before Tax |
-$18.62 B
|
-$20.80 M
|
-$37.47 M
|
-$22.15 M
|
-$23.33 M
|
-$18.67 M
|
-$22.30 M
|
-$20.40 M
|
-$22.05 M
|
-$22.46 M
|
| Income Before Tax Ratio |
0
|
0
|
-74.93
|
-44.31
|
-46.66
|
-37.34
|
-44.6
|
-40.8
|
-44.11
|
-44.92
|
| Income Tax Expense |
$0.00
|
-$1.28 M
|
-$1.57 M
|
-$1.38 M
|
-$1.85 M
|
-$1.82 M
|
-$10.42 M
|
$1.93 M
|
$1.40 M
|
$1.61 M
|
| Net Income |
-$18.62 B
|
-$19.51 M
|
-$35.90 M
|
-$20.77 M
|
-$21.48 M
|
-$16.85 M
|
-$11.88 M
|
-$20.40 M
|
-$22.05 M
|
-$22.46 M
|
| Net Income Ratio |
0
|
0
|
-71.8
|
-41.54
|
-42.97
|
-33.7
|
-23.77
|
-40.8
|
-44.11
|
-44.92
|
| EPS |
-1618 |
-2.16 |
-5.03 |
-3.6 |
-10.08 |
-11.58 |
-10.14 |
-40.12 |
-178.43 |
-216.24 |
| EPS Diluted |
-1618 |
-2.16 |
-5.03 |
-3.6 |
-10.08 |
-11.58 |
-10.14 |
-40.12 |
-178.42 |
-216.24 |
| Weighted Average Shares Out |
$11.51 M
|
$9.05 M
|
$7.14 M
|
$5.77 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508,480.00
|
$123,603.00
|
$103,872.00
|
| Weighted Average Shares Out Diluted |
$11.51 M
|
$9.05 M
|
$7.14 M
|
$5.77 M
|
$2.13 M
|
$1.46 M
|
$1.17 M
|
$508,483.00
|
$123,604.00
|
$103,873.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
